Swiss Life Asset Management Ltd

Position in ELAN — Elanco Animal Health Inc

CIK 1637689 Zurich, V8

Back to ELAN Full portfolio

Position in ELAN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,053,183

+$250,022 QoQ

Shares Held

44,011

+24.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Swiss Life Asset Management Ltd holds $41,003,042 across 18 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	174,361	$20,611,212
2	UTHR	UNITED THERAPEUTICS Corp	15,776	$9,354,852
3	TEVA	Teva Pharmaceutical Industries Ltd	101,990	$3,071,938
4	NBIX	Neurocrine Biosciences Inc	20,740	$2,732,287
5	VTRS	Viatris Inc	100,279	$1,354,769
6	ELAN	Elanco Animal Health Inc This page	44,011	$1,053,183
7	INDV	Indivior Pharmaceuticals, Inc.	19,034	$580,156
8	PBH	Prestige Consumer Healthcare Inc.	5,872	$348,033

All Filings in ELAN

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,053,183	44,011	+24.0%	Shares	Sole	2026-05-14
2025-12-31	$803,161	35,491	+55.7%	Shares	Sole	2026-02-04
2025-09-30	$458,970	22,789	+79.1%	Shares	Sole	2025-12-02
2025-06-30	$181,670	12,722	-90.7%	Shares	Sole	2025-12-02
2023-06-30	$1,377,093	136,888	0.0%	Shares	Sole	2025-12-09
2023-03-31	$1,286,747	136,888	+1301.5%	Shares	Sole	2025-12-09
2022-06-30	$191,726	9,767	+3155.7%	Shares	Defined	2025-12-09
2021-06-30	$10,407	300	-97.0%	Shares	Defined	2025-12-29
2020-03-31	$226,989	10,138	—	Shares	Sole	2025-12-29
No filing history on record for this holder in this stock.